TNF-α is an attractive target for the development of anti-inflammatory drugs because it is an important mediator in the pathogenesis of several inflammatory diseases, including RA, Crohn ̓s disease and ankylosing spondylitis. The gene discussed is TNF; the disease is ankylosing spondylitis.